NAD+and SIRT3 control microtubule dynamics and reduce susceptibility to antimicrotubule agents

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 24, 2014, Pages

  Harkcom, William T ^a   Ghosh, Ananda K ^a   Sung, Matthew S ^a   Matov, Alexandre ^a   Brown, Kevin D ^a   Giannakakou, Paraskevi ^a   Jaffrey, Samie R ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMICROTUBULE AGENT; ANTINEOPLASTIC AGENT; NAVELBINE; NICOTINAMIDE ADENINE DINUCLEOTIDE; POLYMER; SIRTUIN 3; UNCLASSIFIED DRUG; VINBLASTINE; VINDESINE;

ARTICLE; CYTOTOXICITY; HUMAN; HUMAN CELL; MICROTUBULE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; AXONS; COLCHICINE; COMET ASSAY; CYTOSKELETON; GANGLIA, SPINAL; GENE EXPRESSION REGULATION; HUMANS; MCF-7 CELLS; MICROTUBULES; MITOCHONDRIA; NAD; NEURONS; NOCODAZOLE; POLYMERS; RATS; REACTIVE OXYGEN SPECIES; SIRTUIN 3; TUBULIN MODULATORS; VINBLASTINE;

EID: 84902602978     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1404269111     Document Type: Article

References (76)

1. Ziegler M (2000) New functions of a long-known molecule. Emerging roles of NAD in cellular signaling. Eur J Biochem 267(6):1550-1564.
2. Blander G, Guarente L (2004) The Sir2 family of protein deacetylases. Annu Rev Biochem 73:417-435. (Pubitemid 39050375)
3. Yang H, et al. (2007) Nutrient-sensitive mitochondrial NAD+ levels dictate cell survival. Cell 130(6):1095-1107. (Pubitemid 47410271)
4. Araki T, Sasaki Y, Milbrandt J (2004) Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science 305(5686):1010-1013. (Pubitemid 39071777)
5. Alano CC, Ying W, Swanson RA (2004) Poly(ADP-ribose) polymerase-1- mediated cell death in astrocytes requires NAD+ depletion and mitochondrial permeability transition. J Biol Chem 279(18):18895-18902. (Pubitemid 38623317)
6. Olesen UH, Hastrup N, Sehested M (2011) Expression patterns of nicotinamide phosphoribosyltransferase and nicotinic acid phosphoribosyltransferase in human malignant lymphomas. APMIS 119(4-5):296-303.
7. Pittelli M, et al. (2011) Pharmacological effects of exogenous NAD on mitochondrial bioenergetics, DNA repair, and apoptosis. Mol Pharmacol 80(6):1136-1146.
8. Cantó C, et al. (2012) The NAD(+) precursor nicotinamide riboside enhances oxidative metabolismand protects against high-fat diet-induced obesity. Cell Metab 15(6):838-847.
9. Wang J, et al. (2005) A local mechanism mediates NAD-dependent protection of axon degeneration. J Cell Biol 170(3):349-355. (Pubitemid 41126935)
10. Mack TG, et al. (2001) Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene. Nat Neurosci 4(12):1199-1206. (Pubitemid 33135625)
11. Fischer LR, et al. (2005) The WldS gene modestly prolongs survival in the SOD1G93A fALS mouse. Neurobiol Dis 19(1-2):293-300. (Pubitemid 40544747)
12. Kaneko S, et al. (2006) Protecting axonal degeneration by increasing nicotinamide adenine dinucleotide levels in experimental autoimmune encephalomyelitis models. J Neurosci 26(38):9794-9804. (Pubitemid 44427718)
13. Beirowski B, Babetto E, Coleman MP, Martin KR (2008) The WldS gene delays axonal but not somatic degeneration in a rat glaucoma model. Eur J Neurosci 28(6):1166-1179.
14. Meyer zu Horste G, et al. (2011) The Wlds transgene reduces axon loss in a Charcot-Marie-Tooth disease 1A rat model and nicotinamide delays post-traumatic axonal degeneration. Neurobiol Dis 42(1):1-8.
15. Sasaki Y, Vohra BPS, Lund FE, Milbrandt J (2009) Nicotinamide mononucleotide adenylyl transferase-mediated axonal protection requires enzymatic activity but not increased levels of neuronal nicotinamide adenine dinucleotide. J Neurosci 29(17):5525-5535.
16. Hengst U, Deglincerti A, Kim HJ, Jeon NL, Jaffrey SR (2009) Axonal elongation triggered by stimulus-induced local translation of a polarity complex protein. Nat Cell Biol 11(8):1024-1030.
17. Wang JT, Medress ZA, Barres BA (2012) Axon degeneration: Molecular mechanisms of a self-destruction pathway. J Cell Biol 196(1):7-18.
18. Jordan MA, Wilson L (2004) Microtubules as a target for anticancer drugs. Nat Rev Cancer 4(4):253-265. (Pubitemid 38525281)
19. Jordan MA, Thrower D, Wilson L (1991) Mechanism of inhibition of cell proliferation by Vinca alkaloids. Cancer Res 51(8):2212-2222.
20. Yang H, Ganguly A, Cabral F (2010) Inhibition of cell migration and cell division correlates with distinct effects of microtubule inhibiting drugs. J Biol Chem 285(42):32242-32250.
21. Gigant B, et al. (2005) Structural basis for the regulation of tubulin by vinblastine. Nature 435(7041):519-522. (Pubitemid 40734250)
22. Gigant B, Cormier A, Dorléans A, Ravelli RBG, Knossow M (2009) Microtubule-destabilizing agents: structural and mechanistic insights from the interaction of colchicine and vinblastine with tubulin. Top Curr Chem 286:259-278.
23. Marcus AI, et al. (2005) The synergistic combination of the farnesyl transferase inhibitor lonafarnib and paclitaxel enhances tubulin acetylation and requires a functional tubulin deacetylase. Cancer Res 65(9):3883-3893. (Pubitemid 40616370)
24. Jordan MA, Toso RJ, Thrower D, Wilson L (1993) Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations. Proc Natl Acad Sci USA 90(20):9552-9556. (Pubitemid 23315823)
25. Dhamodharan R, Jordan MA, Thrower D, Wilson L, Wadsworth P (1995) Vinblastine suppresses dynamics of individual microtubules in living interphase cells. Mol Biol Cell 6(9):1215-1229.
26. Jordan MA (2002) Mechanism of action of antitumor drugs that interact with microtubules and tubulin. Curr Med Chem Anticancer Agents 2(1):1-17. (Pubitemid 34649866)
27. Matov A, et al. (2010) Analysis of microtubule dynamic instability using a plus-end growth marker. Nat Methods 7(9):761-768.
28. Long JB, et al. (2013) Multiparametric analysis of CLASP-interacting protein functions during interphase microtubule dynamics. Mol Cell Biol 33(8):1528-1545.
29. Komarova YA, Vorobjev IA, Borisy GG (2002) Life cycle of MTs: Persistent growth in the cell interior, asymmetric transition frequencies and effects of the cell boundary. J Cell Sci 115(Pt 17):3527-3539. (Pubitemid 34994042)
30. Piehl M, Cassimeris L (2003) Organization and dynamics of growing microtubule plus ends during early mitosis. Mol Biol Cell 14(3):916-925. (Pubitemid 36337442)
31. Stepanova T, et al. (2003) Visualization of microtubule growth in cultured neurons via the use of EB3-GFP (end-binding protein 3-green fluorescent protein). J Neurosci 23(7):2655-2664. (Pubitemid 36418600)
32. Emanuelli M, et al. (2001) Molecular cloning, chromosomal localization, tissue mRNA levels, bacterial expression, and enzymatic properties of human NMN adenylyl-transferase. J Biol Chem 276(1):406-412. (Pubitemid 32050333)
33. Xu K, Schwarz PM, Luduena RF (2002) Interaction of nocodazole with tubulin isotypes. Drug Dev Res 55(2):91-96.
34. Michan S, Sinclair D (2007) Sirtuins in mammals: Insights into their biological function. Biochem J 404(1):1-13. (Pubitemid 46788079)
35. He W, Newman JC, Wang MZ, Ho L, Verdin E (2012) Mitochondrial sirtuins: Regulators of protein acylation and metabolism. Trends Endocrinol Metab 23(9):467-476.
36. Rodgers JT, et al. (2005) Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 434(7029):113-118. (Pubitemid 40349395)
37. Kong X, et al. (2010) Sirtuin 3, a new target of PGC-1alpha, plays an important role in the suppression of ROS and mitochondrial biogenesis. PLoS ONE 5(7):e11707.
38. North BJ, Marshall BL, Borra MT, Denu JM, Verdin E (2003) The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase. Mol Cell 11(2):437-444. (Pubitemid 36293837)
39. Bell EL, Guarente L (2011) The SirT3 divining rod points to oxidative stress. Mol Cell 42(5):561-568.
40. Hebert AS, et al. (2013) Calorie restriction and SIRT3 trigger global reprogramming of the mitochondrial protein acetylome. Mol Cell 49(1):186-199.
41. Someya S, et al. (2010) Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction. Cell 143(5):802-812.
42. Qiu X, Brown K, Hirschey MD, Verdin E, Chen D (2010) Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation. Cell Metab 12(6):662-667.
43. Bell EL, Emerling BM, Ricoult SJH, Guarente L (2011) SirT3 suppresses hypoxia inducible factor 1α and tumor growth by inhibiting mitochondrial ROS production. Oncogene 30(26):2986-2996.
44. Mahoney JR, Graf E (1986) Role of alpha-tocopherol, ascorbic acid, citric acid and EDTA as oxidants in model systems. J Food Sci 51(5):1293-1296.
45. Reilein A, NelsonWJ (2005) APC is a component of an organizing template for cortical microtubule networks. Nat Cell Biol 7(5):463-473. (Pubitemid 40637406)
46. Haigis MC, et al. (2006) SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells. Cell 126(5):941-954. (Pubitemid 44321935)
47. Ahuja N, et al. (2007) Regulation of insulin secretion by SIRT4, a mitochondrial ADP-ribosyltransferase. J Biol Chem 282(46):33583-33592. (Pubitemid 350159524)
48. Du J, et al. (2011) Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase. Science 334(6057):806-809.
49. Lombard DB, et al. (2007) Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation. Mol Cell Biol 27(24):8807-8814.
50. Cooper HM, Spelbrink JN (2008) The human SIRT3 protein deacetylase is exclusively mitochondrial. Biochem J 411(2):279-285. (Pubitemid 351580180)
51. Cooper HM, Huang J-Y, Verdin E, Spelbrink JN (2009) A new splice variant of the mouse SIRT3 gene encodes the mitochondrial precursor protein. PLoS ONE 4(3):e4986.
52. Sol EM, et al. (2012) Proteomic investigations of lysine acetylation identify diverse substrates of mitochondrial deacetylase sirt3. PLoS ONE 7(12):e50545.
53. Finkel T (2011) Signal transduction by reactive oxygen species. J Cell Biol 194(1):7-15.
54. Banan A, et al. (2002) Activation of delta-isoform of protein kinase C is required for oxidant-induced disruption of both the microtubule cytoskeleton and permeability barrier of intestinal epithelia. J Pharmacol Exp Ther 303(1):17-28.
55. Magnifico S, et al. (2013) NAD+ acts on mitochondrial SirT3 to prevent axonal caspase activation and axonal degeneration. FASEB J 27(12):4712-4722.
56. Hellal F, et al. (2011) Microtubule stabilization reduces scarring and causes axon regeneration after spinal cord injury. Science 331(6019):928-931.
57. Sengottuvel V, Leibinger M, Pfreimer M, Andreadaki A, Fischer D (2011) Taxol facilitates axon regeneration in the mature CNS. J Neurosci 31(7):2688-2699.
58. Ertürk A, Hellal F, Enes J, Bradke F (2007) Disorganized microtubules underlie the formation of retraction bulbs and the failure of axonal regeneration. J Neurosci 27(34):9169-9180. (Pubitemid 47312058)
59. Nakahata Y, Sahar S, Astarita G, Kaluzova M, Sassone-Corsi P (2009) Circadian control of the NAD+ salvage pathway by CLOCK-SIRT1. Science 324(5927):654-657.
60. Kim H-J, et al. (2011) Metabolomic analysis of livers and serum from high-fat diet induced obese mice. J Proteome Res 10(2):722-731.
61. Virág L, et al.; Garcia Soriano F (2001) Diabetic endothelial dysfunction: The role of poly(ADP-ribose) polymerase activation. Nat Med 7(1):108-113.
62. Charron MJ, Bonner-Weir S (1999) Implicating PARP and NAD+ depletion in type I diabetes. Nat Med 5(3):269-270. (Pubitemid 29124357)
63. Mouchiroud L, et al. (2013) The NAD(+)/sirtuin pathway modulates longevity through activation of mitochondrial UPR and FOXO signaling. Cell 154(2):430-441.
64. Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414(6865):813-820.
65. Wang B, et al. (2011) NAMPT overexpression in prostate cancer and its contribution to tumor cell survival and stress response. Oncogene 30(8):907-921.
66. von Heideman A, Berglund A, Larsson R, Nygren P (2010) Safety and efficacy of NAD depleting cancer drugs: Results of a phase I clinical trial of CHS 828 and overview of published data. Cancer Chemother Pharmacol 65(6):1165-1172.
67. Galli U, et al. (2013) Medicinal chemistry of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors. J Med Chem 56(16):6279-6296.
68. Pittelli M, et al. (2010) Inhibition of nicotinamide phosphoribosyltransferase: Cellular bioenergetics reveals a mitochondrial insensitive NAD pool. J Biol Chem 285(44):34106-34114.
69. Schindelin J, et al. (2012) Fiji: An open-source platform for biological-image analysis. Nat Methods 9(7):676-682.
70. Gierke S, Wittmann T (2012) EB1-recruited microtubule +TIP complexes coordinate protrusion dynamics during 3D epithelial remodeling. Curr Biol 22(9):753-762.
71. Thoma CR, et al. (2010) Quantitative image analysis identifies pVHL as a key regulator of microtubule dynamic instability. J Cell Biol 190(6):991-1003.
72. Wu KY, et al. (2005) Local translation of RhoA regulates growth cone collapse. Nature 436(7053):1020-1024. (Pubitemid 41191685)
73. Taylor AM, et al. (2005) A microfluidic culture platform for CNS axonal injury, regeneration and transport. Nat Methods 2(8):599-605. (Pubitemid 41086851)
74. Dull T, et al. (1998) A third-generation lentivirus vector with a conditional packaging system. J Virol 72(11):8463-8471. (Pubitemid 28471781)
75. Hesterberg T, Monaghan S, Moore D (2005) Bootstrap methods and permutation tests. Introd to Pract Stat 5:1-70.
76. Desai A, Mitchison TJ (1997) Microtubule polymerization dynamics. Annu Rev Cell Dev Biol 13:83-117. (Pubitemid 28034521)